# Halscion

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/halscion

- Industry: Healthcare
- Headquarters: Suwanee, US
- Website: www.halscion.net
- Total disclosed funding: $14M
- Latest round: Series B (Apr 6, 2011)
- Investors on record: 4

## About

Halscion is an innovative online gaming platform that specializes in slot games and casino-style offerings, designed to engage a diverse player base through interactive and user-friendly experiences.Founded in 2008 and headquartered in Suwanee, US, Halscion operates primarily in the online gaming industry, offering a variety of slot games. The company had its most recent funding round, a Series B, in April 2011, raising USD 3.5 mn from investors including Accuitive Medical Ventures, SV Health Investors, and Versant Ventures. The CEO is Kathleen Beauchamp, who has a history in the gaming sector and has previously founded other companies. Halscion has successfully completed three deals to date, with a current valuation of USD 21.74 mn.Halscion focuses on providing an extensive online gaming platform, primarily targeting slot games and various casino-style games. Its offerings include a wide range of themes and gameplay mechanics to cater to different player demographics. The platform features user engagement enhancements, such as free game trials and promotional bonuses, appealing to both casual gamers and serious investors. The service is accessible via mobile devices, ensuring extensive market reach, particularly in Southeast Asia.Halscion generates revenue through a direct-to-consumer model, relying on user transactions on its gaming platform. Players can deposit funds for gaming, with a minimum deposit that allows flexible spending. Revenue is derived from a percentage of user bets, alongside in-game purchases and premium subscriptions. The transaction structure is designed for a seamless user experience from registration to gameplay, bolstered by promotional strategies that attract new customers, enhancing player retention.Halscion is poised for growth, focusing on the launch of new gaming products and exploring expansion into additional geographic markets. The recent Series B funding of USD 3.5 mn will support the development of these upcoming products, as well as plans to reach new users in various regions. The company aims to enhance its offerings and strengthen its market presence in Southeast Asia and beyond by leveraging insights from the latest investment round.

## Funding rounds

- Series B, Apr 6, 2011, $3.5M — Versant Ventures, Accuitive Medical Ventures, SV Health Investors
- Series B, Oct 16, 2009, $6M — Versant Ventures, Accuitive Medical Ventures, SV Health Investors, The Innovation Factory
- Series A, Jan 1, 2008, $4.5M — Versant Ventures, Accuitive Medical Ventures, SV Health Investors

## Investors

- Versant Ventures (https://capitalatlas.ai/funds/versant-ventures) — Series A, Series B
- Accuitive Medical Ventures (https://capitalatlas.ai/funds/accuitive-medical-ventures) — Series A, Series B
- SV Health Investors (https://capitalatlas.ai/funds/sv-health-investors) — Series A, Series B
- The Innovation Factory — Series B